JPS6463379A - Cellulose soluble protein - Google Patents

Cellulose soluble protein

Info

Publication number
JPS6463379A
JPS6463379A JP63125612A JP12561288A JPS6463379A JP S6463379 A JPS6463379 A JP S6463379A JP 63125612 A JP63125612 A JP 63125612A JP 12561288 A JP12561288 A JP 12561288A JP S6463379 A JPS6463379 A JP S6463379A
Authority
JP
Japan
Prior art keywords
soluble protein
cellulose soluble
cellulose
protein
soluble
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP63125612A
Other languages
English (en)
Inventor
Aaru Marubihiru Airiin
Shii Fuosutaa Donarudo
Jiei Ohara Patoritsuku
Ashitsuku Kamaa Anaa
Deii Rao Donarudo
Wai Insuree Maagaretsuto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zymogenetics Inc
Original Assignee
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymogenetics Inc filed Critical Zymogenetics Inc
Publication of JPS6463379A publication Critical patent/JPS6463379A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
JP63125612A 1987-05-22 1988-05-23 Cellulose soluble protein Pending JPS6463379A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5341187A 1987-05-22 1987-05-22

Publications (1)

Publication Number Publication Date
JPS6463379A true JPS6463379A (en) 1989-03-09

Family

ID=21984041

Family Applications (1)

Application Number Title Priority Date Filing Date
JP63125612A Pending JPS6463379A (en) 1987-05-22 1988-05-23 Cellulose soluble protein

Country Status (7)

Country Link
EP (1) EP0292009A1 (ja)
JP (1) JPS6463379A (ja)
KR (1) KR880013978A (ja)
AU (1) AU626147B2 (ja)
DK (1) DK275788A (ja)
FI (1) FI882407A (ja)
NO (1) NO882226L (ja)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5079159A (en) * 1983-12-27 1992-01-07 Genetics Institute, Inc. Method for making tissue plasminogen activator
US5756093A (en) * 1985-04-22 1998-05-26 Genentech, Inc. Tissue plasminogen activator variants
US5714372A (en) * 1985-04-22 1998-02-03 Genentech, Inc. Tissue plasminogen activator variants
US5736134A (en) * 1985-04-22 1998-04-07 Genentech, In.C Tissue plasminogen activator variants
US5108901A (en) * 1988-09-02 1992-04-28 Genentech, Inc. Tissue plasminogen activator having zymogenic or fibrin specific properties
US5258180A (en) * 1988-09-02 1993-11-02 Genetech, Inc. Tissue plasminogen activator having fibrin specific properties and deletion of amino acids 466-970, compositions and methods of treatment
US5714145A (en) * 1988-09-02 1998-02-03 Genentech, Inc. Tissue plasminogen activator having zymogenic or fibrin specific properties
US5262170A (en) * 1988-09-02 1993-11-16 Genentech, Inc. Tissue plasminogen activator having zymogenic or fibrin specific properties and substituted at amino acid positions 296-299, DNA molecules encoding them, vectors, and host cells
US5550042A (en) * 1989-03-06 1996-08-27 The Board Of Regents Of The University Of Texas System Serine protease mutants of the chymotrypsin superfamily resistant to inhibition by their cognate inhibitors and genes encoding the same and serine protease inhibitor mutants and genes encoding the same
DE69033699T2 (de) * 1989-03-06 2001-05-23 The Board Of Regents Of The University Of Texas System, Austin Gegenüber eigenen inhibitoren resistente t-pa mutanten
US5866413A (en) * 1989-03-06 1999-02-02 Board Of Regents Of The University Of Texas System Pai-1 mutants
US5190756A (en) * 1989-12-01 1993-03-02 Genentech, Inc. Methods and materials for expression of human plasminogen variant
US5087572A (en) * 1989-12-01 1992-02-11 Genentech, Inc. Dna encoding human plasminogen modified at the cleavage site
GB8927722D0 (en) * 1989-12-07 1990-02-07 British Bio Technology Proteins and nucleic acids
US5242688A (en) * 1990-12-24 1993-09-07 Eli Lilly And Company Method of treating thromboembolic disorders by administration of diglycosylated t-pa variants
EP0618964A4 (en) * 1991-12-16 1995-12-06 Genentech Inc Novel tissue plasminogen activator variants.
ATE145669T1 (de) * 1991-12-16 1996-12-15 Genentech Inc T-pa substitutionsvarianten mit verbesserter fibrinspezifität
AU664469B2 (en) * 1992-06-03 1995-11-16 Genentech Inc. Tissue plasminogen activator glycosylation variants with improved therapeutic properties
WO1997038087A2 (en) 1996-04-05 1997-10-16 Chiron Corporation Alphaviral vector with reduced inhibition of cellular macromolecular synthesis
US6706504B1 (en) 1996-11-12 2004-03-16 The Scripps Research Institute Tissue type plasminogen activator (t-PA) variants: compositions and methods of use
EP1636356A1 (en) * 2003-06-11 2006-03-22 Schering Aktiengesellschaft Novel modified corin molecules having substitute activation sequences and uses thereof

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0178105A2 (en) * 1984-10-01 1986-04-16 Genzyme Corporation Recombinant DNA techniques and the products thereof
JPS6224A (ja) * 1985-04-22 1987-01-06 ジエネンテク，インコ−ポレイテツド 新規なヒト組織プラスミノゲン活性化因子突然変異体
JPS6226234A (ja) * 1985-05-28 1987-02-04 ザ　ウエルカム　フアウンデ−シヨン　リミテツド 非経口溶液製剤
JPS62104577A (ja) * 1985-08-14 1987-05-15 アメリカン・ホ−ム・プロダクツ・コ−ポレイシヨン ポリクリングルプラスミノ−ゲン活性化因子
JPS63501335A (ja) * 1986-01-31 1988-05-26 ジェネティックス・インスチチュ−ト・インコ−ポレ−テッド 新しい血栓溶解タンパク質

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0125254A1 (en) * 1982-10-28 1984-11-21 Beecham Group Plc Enzyme derivatives and their use in the treatment of thrombosis
US4753879A (en) * 1984-08-27 1988-06-28 Biogen N.V. Modified tissue plasminogen activators
AU605124B2 (en) * 1985-12-23 1991-01-10 Behringwerke Aktiengesellschaft Novel peptide plasminogen activators
DK43387A (da) * 1986-01-29 1987-07-30 Beecham Group Plc Fibrinolytisk enzym
GB8608020D0 (en) * 1986-04-02 1986-05-08 Beecham Group Plc Compounds

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0178105A2 (en) * 1984-10-01 1986-04-16 Genzyme Corporation Recombinant DNA techniques and the products thereof
JPS6224A (ja) * 1985-04-22 1987-01-06 ジエネンテク，インコ−ポレイテツド 新規なヒト組織プラスミノゲン活性化因子突然変異体
JPS6226234A (ja) * 1985-05-28 1987-02-04 ザ　ウエルカム　フアウンデ−シヨン　リミテツド 非経口溶液製剤
JPS62104577A (ja) * 1985-08-14 1987-05-15 アメリカン・ホ−ム・プロダクツ・コ−ポレイシヨン ポリクリングルプラスミノ−ゲン活性化因子
JPS63501335A (ja) * 1986-01-31 1988-05-26 ジェネティックス・インスチチュ−ト・インコ−ポレ−テッド 新しい血栓溶解タンパク質

Also Published As

Publication number Publication date
AU1652888A (en) 1988-11-24
NO882226D0 (no) 1988-05-20
KR880013978A (ko) 1988-12-22
NO882226L (no) 1988-11-23
AU626147B2 (en) 1992-07-23
DK275788A (da) 1989-02-03
EP0292009A1 (en) 1988-11-23
FI882407A0 (fi) 1988-05-20
FI882407A (fi) 1988-11-23
DK275788D0 (da) 1988-05-20

Similar Documents

Publication Publication Date Title
GR3002864T3 (en) Azolylmethylcyclopropyl derivatives
YU234188A (en) Adenozine derivatives
JPS6463379A (en) Cellulose soluble protein
PH25327A (en) Binfunctional proteins
GB8724412D0 (en) Protein
EP0318704A3 (en) 3-cyano-4-phenyl-pyrrole derivatives
GB8815258D0 (en) Thiorea derivatives
GB8604655D0 (en) Cigarettes
EP0305322A3 (en) Isoxazole-beta-carboline derivatives
EP0297383A3 (en) Hydroxyethyl-azolyl derivatives
GB2205829B (en) 2-aryl-4-isoxazolin-3-one derivatives
GB8705601D0 (en) Oxo-isoindolinyl derivatives
GB8713559D0 (en) Structural proteins
GB2200910B (en) Thiopilocarpine derivatives
GB8725462D0 (en) Protein
GB8704236D0 (en) Anthracycline-oestrone derivatives
GB8725463D0 (en) Protein
GB8700016D0 (en) Quinolizinone derivatives
GB8725568D0 (en) Connecting means
GB8708635D0 (en) Fr-900848 substance
GB8715925D0 (en) Thiapentanamide derivatives
GB2211840B (en) Indenofuran derivatives
GB8702714D0 (en) Impedance t-attenuator
IE871681L (en) Cytorhodin s derivatives
IE862835L (en) Protein modification